Literature DB >> 6944438

Friend disease in vitro.

T M Dexter, T D Allen, N G Testa, E Scolnick.   

Abstract

In long-term marrow cultures, hemopoiesis can be maintained for several months, although erythropoiesis is normally suppressed at the most primitive level of development (the erythroid colony-forming cells). Infection of these cultures with a viral complex combining helper-independent murine leukemia virus (F-MuLV) and a spleen focus-forming virus (SFFVp) results in a productive infection of both the replication defective SFFVp and the F-MuLV. After infection, the cultures show a dramatic elevation in the numbers of late erythroid progenitor cells (CFU-E), many of which will grow in the absence of added erythropoietin, and a transient erythropoietin, independent erythropoiesis, including the production of mature, enucleated erythrocytes. Hemopoiesis eventually declines, with no evidence for the generation of Friend tumor cells. When erythropoiesis is induced in the long-term cultures by addition of anemic mouse serum before infection by polycythemia-inducing Friend virus, the generation of erythropoietin-independent CFU-E and erythrocyte formation is followed by the sustained production (greater than 40 wk) of primitive erythroid cells with low spontaneous levels (less than 5%) of hemoglobinization. Although these cells will produce spleen colonies in irradiated mice and can be cloned in soft-gel media, they do not produce autonomous, permanently growing cell lines in vitro, i.e., they retain a dependency upon the marrow-adherent layer for their continued growth. However, following a further passage on a "virgin" marrow environment, permanent cell lines can be established that are able to grow independently of environmental influences. Thus, this system is the first description of a complete in vitro system for the reproducible production and isolation of Friend virus-induced erythroid cell lines.

Entities:  

Mesh:

Year:  1981        PMID: 6944438      PMCID: PMC2186442          DOI: 10.1084/jem.154.3.594

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

3.  Erythropoietin-independent erythroid colony formation in vitro by hemopoietic cells of mice infected with friend virus.

Authors:  S K Liao; A A Axelrad
Journal:  Int J Cancer       Date:  1975-03-15       Impact factor: 7.396

4.  Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex.

Authors:  R A Steeves; R J Eckner; M Bennett; E A Mirand; P J Trudel
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

5.  Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.

Authors:  C Friend; W Scher; J G Holland; T Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

6.  Fv-2 locus controls expression of Friend spleen focus-forming virus-specific sequences in normal and infected mice.

Authors:  T W Mak; A A Axelrad; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Host restriction of Friend leukemia virus: synthesis and integration of the provirus.

Authors:  M M Sveda; R Soeiro
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

8.  Release of spleen focus-forming virus (SFFV) from differentiation inducible promyelocytic leukemia cell lines transformed in vitro by Friend leukemia virus.

Authors:  J S Greenberger; R J Eckner; W Ostertag; G Colletta; S Boschetti; H Nagasawa; A Karpas; R R Weichselbaum; W C Moloney
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

9.  Polycythemia- and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro.

Authors:  W D Hankins; D Troxler
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

10.  Anemia- and polycythemia-inducing isolates of Friend spleen focus-forming virus. Biological and molecular evidence for two distinct viral genomes.

Authors:  M E MacDonald; F H Reynolds; W J Van de Ven; J R Stephenson; T W Mak; A Bernstein
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  9 in total

1.  The Ets-related transcription factor PU.1 immortalizes erythroblasts.

Authors:  S Schuetze; P E Stenberg; D Kabat
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

2.  Expression of a transformation-related protein (p53) in the malignant stage of Friend virus-induced diseases.

Authors:  S K Ruscetti; E M Scolnick
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

3.  Hemopoietic stem cells and target cells in murine-virus-induced leukemias.

Authors:  H J Seidel
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

4.  Target cells for avian myeloblastosis virus in embryonic yolk sac and relationship of cell differentiation to cell transformation.

Authors:  D Boettiger; E Durban
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Myelo-lymphopoiesis in long-term bone marrow culture.

Authors:  H G Mergenthaler
Journal:  Klin Wochenschr       Date:  1985-04-15

6.  Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice.

Authors:  Q X Li; H Fan
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  Multistep virus-induced leukemogenesis in vitro: description of a model specifying three steps within the myeloblastic malignant process.

Authors:  J M Heard; S Fichelson; B Sola; M A Martial; B Varet; J P Levy
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

8.  Isolation of immortal cell lines from the first stage of murine leukemia virus-induced leukemia.

Authors:  A Oliff; I Oliff; B Schmidt; N Famulari
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

Review 9.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.